Reimbursed with a limitationGenericATC B02BX05

Eltrombopag-Mepha

Eltrombopag-Mepha is a generic from Mepha Pharma AG and is listed on the FOPH Specialities List. Basic health insurance reimburses it within the authorised indication. The public price ranges from CHF 230.95 to CHF 1'303.75 depending on the pack; the co-payment is 10 per cent.

Core data

Authorisation holder
Mepha Pharma AG
ATC code
B02BX05
IT group
06.99 Varia
Active substances
Eltrombopagum
Preparation type
Generic
On the SL since
01/12/2025
Last price change
01/02/2026
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Eltrombopag-Mepha Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Filmtabl 25 mgBlist 14 StkCHF 194.15CHF 230.9501/12/2025A7680698430018
Filmtabl 25 mgBlist 28 StkCHF 388.30CHF 445.5501/12/2025A7680698430025
Filmtabl 50 mgBlist 14 StkCHF 388.30CHF 445.5501/12/2025A7680698430032
Filmtabl 50 mgBlist 28 StkCHF 776.60CHF 874.6501/12/2025A7680698430049
Filmtabl 75 mgBlist 28 StkCHF 1'164.90CHF 1'303.7501/12/2025A7680698430056

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingIndication 22012.03Valid from 01/08/2026

Immunthrombozytopenische Purpura (ITP) – Erwachsene
Zur Behandlung von erwachsenen Patienten mit einer mindestens 6 Monate ab Diagnose dauernden (idiopathischen) immunthrombozytopenischen Purpura (ITP), die auf andere Therapieoptionen (z.B. Kortikosteroide, Immunglobuline oder Splenektomie) nicht genügend ansprachen, bei erhöhtem Blutungsrisiko infolge ausgeprägter Thrombozytopenie. Die Behandlung soIIte abgebrochen werden, wenn nach vierwöchiger Therapie mit 75 mg/Tag die Thrombozytenwerte nicht ausreichend ansteigen.
Der Indikationscode dieser Limitierung ist an den Krankenversicherer zu übermitteln.

FOPH wordingIndication 22012.04Valid from 01/08/2026

Immunthrombozytopenische Purpura (ITP) – Kinder ab 6 Jahren 
Zur Behandlung von pädiatrischen Patienten (6 Jahre und älter) mit einer mindestens 6 Monate ab Diagnose dauernden (idiopathischen) immunthrombozytopenischen Purpura (ITP) und relevanter Blutungsneigung, die auf eine etablierte Behandlung (z.B. IVIG, Kortikosteroide) nicht angesprochen haben und für die eine Splenektomie keine Behandlungsoption dar-stellt. Dosisreduktionen bei pädiatrischen Patienten müssen regelmässig geprüft werden.
Der Indikationscode dieser Limitierung ist an den Krankenversicherer zu übermitteln.

 

More preparations in this group

FAQ

Is Eltrombopag-Mepha covered by Swiss health insurance?

Yes, but only under conditions. Eltrombopag-Mepha is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Eltrombopag-Mepha cost in Switzerland?

The public price is the maximum price set by the FOPH and for Eltrombopag-Mepha ranges from CHF 230.95 to CHF 1'303.75 per pack. The ex-factory price ranges from CHF 194.15 to CHF 1'164.90. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com